When SAGENT® was founded, in 2006, we were aware of alarming statistics about medication errors. For example, between 2003 and 2006, 25,5301 errors related to look-alike or sound-alike medications were reported to the Medication Errors Reporting Program
and MEDMARX (an adverse drug event database).
The Institute for Safe Medication Practices (ISMP) had produced a list showing hundreds of drug names that were easily confused because they look alike or sound alike or both, and typical
generic packaging did nothing to relieve the confusion. So it was no surprise to learn that:
As a startup generic injectables company, we realized that we could be part of the solution. So from the launch of our first product, ADENOSINE Injection, USP in 2007, we have made PreventIV Measures Packaging and Labeling a major part of our product offering.
PreventIV Measures Packaging and Labeling is featured on every SAGENT product, including our award-winning HEPARIN family.
Our commitment to patient safety also extends to our premix bag products. On each one, the drug name and strength are printed on the front and back of the overwrap, so the product can be identified immediately and accurately, no matter how it’s stored.
Every product we have manufactured has featured PreventIV Measures Packaging and Labeling. Every product has a unique design and every strength has a distinctive color.
Every product name and strength is prominent and easy to read.
It’s our way of helping make accurate medication selection an easy and obvious choice.
It was our commitment in 2007 and it remains our commitment today.
2 FDA Medication Error Reports. March 5, 2009.
3 Makary MA, Daniel M. Medical error—the third leading cause of death in the US. BMJ 2016;353:i2139.